RBOT (Vicarious Surgical) Cash And Cash Equivalents : $2.60 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical Cash And Cash Equivalents?

Vicarious Surgical's quarterly cash and cash equivalents increased from Sep. 2024 ($7.07 Mil) to Dec. 2024 ($9.74 Mil) but then stayed the same from Dec. 2024 ($9.74 Mil) to Mar. 2025 ($2.60 Mil).

Vicarious Surgical's annual cash and cash equivalents declined from Dec. 2022 ($116.21 Mil) to Dec. 2023 ($52.82 Mil) and declined from Dec. 2023 ($52.82 Mil) to Dec. 2024 ($9.74 Mil).

Vicarious Surgical Cash And Cash Equivalents Historical Data

The historical data trend for Vicarious Surgical's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical Cash And Cash Equivalents Chart

Vicarious Surgical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

16.87

173.51

116.21

52.82

9.74

Vicarious Surgical Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash And Cash Equivalents	Get a 7-Day Free Trial														38.22	20.25	7.07	9.74	2.60

Vicarious Surgical Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Vicarious Surgical (NYSE:RBOT) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Vicarious Surgical Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicarious Surgical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

78 Fourth Avenue, Waltham, MA, USA, 02451

Website

https://www.vicarioussurgical.com

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Executives

Adam David Sachs	director, 10 percent owner, officer: President and CEO	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa	director, 10 percent owner, officer: Chief Technology Officer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
William John Kelly	officer: CFO and Treasurer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola	officer: Chief Operating Officer	TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
June Morris	officer: CLO, General Counsel and Sec	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Khosla Ventures Opportunity Ii, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Associates Ii, Llc	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho	director	UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang	director	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr	director	C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss	director	C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Shrikant Patnaik	other: Principal	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop	director	C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803
Barry Stuart Greene	10 percent owner	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451